Medical Advisory Board

Medical Advisory Board

Kenneth S. Sharlin

Ken Sharlin, M.D., M.P.H., IFMCP, is a board-certified neurologist, consultant, functional medicine practitioner, Assistant Clinical Professor, researcher, author, and speaker. His medical degrees are from Emory University, The University of Virginia, and Vanderbilt University. His functional medicine certification is through The Institute for Functional Medicine. He is author of the #1 best-seller The Healthy Brain Toolbox: Neurologist-Proven Strategies to Improve Memory Loss and Protect Your Aging Brain. His most recent publication, Reversal of Cognitive Decline: 100 Patients, can be found in the peer-reviewed Journal of Alzheimer’s & Parkinsonism, and he has been the primary investigator in several pharma-sponsored clinical trials that have helped bring new therapeutics to market. Dr. Sharlin practices general neurology, and directs his functional medicine program, Brain Tune Up!, in Ozark, MO.

Assistant Professor

Adjunct Clinical Faculty

Kansas City University of Medicine & Biosciences

 

Editorial Board Member, Integrative Practitioner

 

Board certified neurologist with research interests in multiple sclerosis, Alzheimer’s, migraine, epilepsy, and chronic pain. I have a master’s degree in public health with an emphasis in epidemiology & biostatistics. I have been an investigational review board member, and I am certified in Good Clinical Practices.

 

Sharlin Health and Neurology is a full-service privately-owned fully-staffed neurology and functional medicine clinic. We service adult patients with a variety of neurological conditions under a traditional insurance model as well as a direct-pay model focused on lifestyle medicine and identification of the root causes of illness. In addition, we have:

  • a clinical trial research center on site.
  • Met all Security Risk Analysis (SRA) requirements by HHS.
  • First-dosing site certification.
  • a CLIA-certified phlebotomy laboratory.
  • Refrigerated centrifuge on site.
  • -70 degrees and -20 degrees F freezers on site.
  • Cerebrospinal fluid examination performed on site.
  • Diagnostic skin punch biopsy and peripheral nerve block procedures on site.
  • Infusion therapy capability on site.
  • Neuro-diagnostic testing (EEG, NCV/EMG) on site.
  • ECG capability on site.
  • Easy access to FedEx and UPS shipping.
  • Privately-owned compounding pharmacy and Quest draw station on site.

Experience

11/2015- Present      Sharlin Health and Neurology.  Neurologist/Owner.  Private Outpatient Neurology Clinic with an emphasis on clinical research, neurology patient care, and lifestyle medicine.

 

11/2005 – 10/2015  Ozarks Community Hospital, Outpatient Neurologist and Functional Medicine doctor.  Hospital-based outpatient clinic specializing in neurology and functional medicine

 

11/2005 – Present    Ozarks Community Hospital, Consultant Neurologist.  In patient neurology consultations and in-hospital patient management service 

 

1/2013 – 11/2015    QPS-Biokinetics, Investigational Review Board member

 

10/2001 – 9/2005    Branson Neurology & Pain Center, Outpatient Neurologist

 

10/2001 – 9/2005    Skaggs Community Health Center (Cox Branson), Consultant Neurologist.  Inpatient neurology consultations and in-hospital patient management service

 

7/2000 – 9/2001      St. John’s (Mercy) Physicians & Clinics, Outpatient Neurologist

 

7/2000 – 9/2001      St. John’s (Mercy) Regional Health Center, Consultant Neurologist.  Inpatient neurology consultations and in-hospital patient management service

 

7/2000 – 9/2001      St. John’s (Mercy) Regional Health Center, Director, Stroke Program

 

7/1998 – 6/2000      Nashville Neuroscience Group, Outpatient Neurologist.  Employed by Dr. Jan Lewis Brandes (practice owner)

 

7/1998 – 6/2000      Nashville Neuroscience Group, Consultant Neurologist.  Inpatient neurology consultations and in-hospital patient management service at Baptist Hospital, Centennial Hospital, and St. Thomas Hospital

 

Education

1996 – 1998               Vanderbilt University School of Medicine

                                    Residency (PGY-3 and PGY-4), Neurology Residency Program

 

1993 – 1996              University of Virginia School of Medicine

Residency (PGY-2) and Research Associate, Neurology Residency Program

 

1992 – 1993              Emory Affiliated Hospitals

                                    Internship (PGY-1), General Internal Medicine

 

1988 – 1992              Emory University School of Medicine

                                    Doctor of Medicine (M.D.)

 

1987 – 1991              Emory University School of Medicine

                                    Master of Public Health (M.P.H.), Epidemiology Track

 

1982 – 1986              Kenyon College

                                    Bachelor of Arts, Magna Cum Laude in English

 

Additional Education/Certifications

 

Preceptor, Botox (Chronic Migraine) Allergan Neurosciences

 

Neurosonology Mini-Fellowship, Wake Forest University School of Medicine (1998)

 

Institute for Functional Medicine Certified Practitioner

 

Wahls Protocol Certified Health Professional

 

Bredesen Reversal of Cognitive Decline

 

Publications

Bredesen DE, Sharlin KS, Jenkins D, et al. Reversal of Cognitive Decline: 100 Patients. J Alzheimer’s Dis Parkinsonism 2018. 8(5):450.doi 10.4172/2161-0460.1000450.

Sharlin, Ken. The Healthy Brain Toolbox – Neurologist-Proven Strategies to Avoid Memory Loss and Protect Your Aging Brain. Bright Night Publishers, May 2018. ISBN: 981-17320770-1-0.

 

Sharlin KS, Heath GW, Ford ES, Welty TK.  Hypertension and blood pressure awareness among American Indians of the northern plains.  Ethn Dis 1993; 3(4):337-43.

 

Sharlin KS, Beazley MA. Sickle cell trait as a cause of stroke in a 73-year old man: Implications for primary and secondary prevention. Journal of Stroke & Cerebrovascular Diseases 1999; 8(4): 271.

Sharlin KS, Warner JS. Cases from the Vanderbilt Headache Clinic. December 1996.

Research

MDA702-PD

Principal Investigator- Retrospective observational study on Parkinson’s disease patients with motor fluctuations

Novartis COMB157G2399

An open-label, single arm, multi-center extension study evaluating long-term safety, tolerability and effectiveness of ofatumumab in subjects with relapsing multiple sclerosis

Novartis OMB157G2102

Principal Investigator – A 12 week randomized open label parallel group multicenter study to evaluate bioequivalence of 20 mg subcutaneous ofatumumab injected by pre-filled syringe or autoinjector in adult RMS patients. (APLIOS)

Avazzia RA-170612

Sub-Investigator – A multicenter, open-label, experimental, interventional clinical tenant study using Microcurrent as an Adjunct Therapy in wound healing and reducing pain in adult patients with chronic wounds.

Novartis CFTY720DUS40 [FLUENT]

Principal Investigator – A 12-Month, prospective, multicenter, two-cohort,

nonrandomized, open-label study in adult patients with Relapsing Multiple Sclerosis (RMS), to investigate changes in immune phenotype biomarkers after treatment with 0.5 mg fingolimod

Novartis OMB157/Ofatumumab

Principal Investigator – A randomized, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of ofatumumab versus teriflunomide in patients with relapsing multiple sclerosis (ASCLEPIOS).

Novartis FTY720DUS01

Principal Investigator – A 6 month, randomized, active comparator, open-label, multi-center study to evaluate patient outcomes, safety and tolerability of fingolimod 0.5 mg/day in patients with relapsing forms of multiple sclerosis who are candidates for MS therapy change from previous disease modifying therapy (EPOC).

Novartis FYI720DUS09

Principal Investigator – A 12- month, prospective, randomized, active-controlled, open-label study to evaluate the patient retention of fingolimod versus approved first-line disease modifying therapies in adults who are in early stages of treatment for relapsing remitting multiple sclerosis (PREFERMS).

Pfizer A0091047/1179

Principal Investigator – A double-blind, randomized, multicenter efficacy and safety study of pregabalin (Lyrica) as monotherapy in patients with partial seizures.

Pfizer A0081160/1170

Principal Investigator – A open-label, multicenter extension study to determine long-term safety and effectiveness of pregabalin (Lyrica) as monotherapy in patients with partial seizures. 

Professional Memberships

American Academy of Neurology

American Medical Association

Missouri State Medical Association

Greene County Medical Society

Institute for Functional Medicine

Languages

Spanish – limited working proficiency

Interests

Triathlon, swimming, bicycling, running, obstacle racing, CrossFit, skiing, mountain biking, natural foods, farmer’s markets, farm-to-table cuisine, cooking, Paleo lifestyle, ancestral health, sport science, music, art, travel, computers/technology, mind-body, reading blogs and listening to podcasts on any of these subjects.

Personal

Married (Valerie Lynn Sharlin), three children (Gabriel Sharlin, Cooper Griffin, Collier Griffin).

Kenneth S. Sharlin, M.D., M.P.H.

Board Certified in Neurology (ABPN)

Sharlin Health and Neurology

5528 N. Farmer Branch Rd.

Ozark, MO 65721

 

O: 417-485-4330

F: 417-485-4424

C: 417-894-4425

Email: drsharlin@sharlinfxmed.com

Website: https://www.sharlinfxmed.com

Dr. Ellie Campbell

Dr. Campbell is a native Chicagoan with a BS and MS from the University of Illinois, a DO degree from the Kirksville College of Osteopathic Medicine, and a Family Medicine residency from the Medical College of Georgia.  Board certified in Family Medicine for over 25 years, she also holds certification from the American Board of Integrative Medicine.

For thirteen years, Dr. Campbell practiced indigent healthcare in a Community Health Center, but since 2005 has championed a solo, concierge-style integrative, holistic, functional medicine-based family practice.

Dr. Campbell has specialty interests– and lectures internationally on– innovative medical practice design and management, community partnerships, Functional Medicine, Bio-Identical Hormone Replacement Therapy, cardiovascular disease prevention, the oral-systemic connection, solutions to physician burnout and Vitamin D.

She began hosting interdisciplinary meet-up groups in 2010 via her “Consortium of Integrative Care Practitioners of Atlanta”. In 2017, she launched “Revolution Practice,” a concierge medicine teaching platform whereby practitioners are taught the business of how to run a successful membership-style functional medicine practice like hers.

In her spare time, Dr. Campbell enjoys live theater, gardening, healthy cooking, hiking, travel, and playtime with her husband and three college age daughters. Learn more about her and her practice at 

www.campbellfamilymedicine.com   

or

www.RevolutionPractice.com

Dr. Izabella Wentz

Dr. Izabella Wentz, Pharm.D., FASCP is a passionate, innovative and solution focused clinical pharmacist. She has had a passion for health care from a very early age, inspired by her mother, Dr. Marta Nowosadzka, MD.

Fascinated by science and the impact of substances on the human body, Izabella decided to pursue a degree in pharmacy with a dream of one day finding a cure for a disease.

An avid learner and goal-oriented student, she received the PharmD. Degree (Doctor of Pharmacy) from the Midwestern University Chicago College of Pharmacy at the age of 23.

After graduation, she excelled at numerous roles including working as a community pharmacist, a clinical consulting pharmacist and later a medication safety pharmacist. She is a Fellow of the American Society of Consultant Pharmacists and holds certifications in Medication Therapy Management as well as Advanced Diabetes Care.

After moving to a new city, she was given the opportunity to lead a statewide medication safety initiative, transitioning to a career in medication safety and healthcare quality improvement. There, she developed an expertise about the whole systems approach, rapid tests of small change; outcomes tracking and root cause analysis.

After two years of researching Hashimoto’s and Hypothyroidism, she decided to combine emerging knowledge with her quality improvement expertise to run rapid tests of change on herself that led her to discover the root cause of her condition. She has summarized three years of research and two years of testing in her book: Hashimoto’s Thyroiditis: Lifestyle Interventions for Finding and Treating the Root Cause.

In 2017, she published another #1 NY Times bestselling book, Hashimoto’s Protocol: A 90-Day Plan for Reversing Thyroid Symptoms and Getting Your Life Back – a more step-by-step, in-depth plan that streamlines the most effective interventions to reverse the autoimmune damage at the root of Hashimoto’s.

Her most recent publication, Hashimoto’s: Food Pharmacology: Nutrition Protocols and Healing Recipes to Take Charge of Your Thyroid Health, is a cookbook featuring 125 delicious recipes with thyroid-supporting nutrients, strategies for making dietary changes an easy part of one’s life, and protocols that can help transform the body into a safe place so that it can receive the foods needed to heal.

During her time as a consultant pharmacist, Dr. Wentz worked as part of an interdisciplinary team consulting on thousands of complicated patient cases, often caused by rare disorders. She was regarded as an expert in clinical pharmacology and would be called to investigate cause and effect by performing comprehensive medication therapy reviews to help identify and resolve adverse drug events. She quickly became well versed in finding and evaluating emerging research to help address her clients’ unique challenges. Although trained as a pharmacist, she was an ardent champion for lifestyle interventions, which often helped patients much more than any medications.